The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa

被引：0
|
作者：
Hanagasi, HA [1 ]
Kaptanoglu, G [1 ]
Sahin, HA [1 ]
Emre, M [1 ]
机构：
[1] Istanbul Univ, Istanbul Med Sch, Dept Neurol, Behav Neurol & Movement Disorders Unit, TR-34390 Istanbul, Turkey
来源：
MOVEMENT DISORDERS | 2000年 / 15卷 / 05期
关键词：
D O I：
10.1002/1531-8257(200009)15:5<1016::AID-MDS1042>3.0.CO;2-J
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1016 / 1017
页数：2
相关论文
共 48 条
  • [1] Memantine improves L-dopa induced dyskinesias
    Varanese, S.
    Howard, J.
    Di Rocco, A.
    MOVEMENT DISORDERS, 2009, 24 : S360 - S360
  • [2] MIRTAZAPINE - AN UNDERRATED DRUG FOR L-DOPA INDUCED DYSKINESIAS
    Verma, O.
    Singh, H.
    Sawal, N.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E70 - E70
  • [3] Functional alteration by NMDA antagonist: Effects of L-Dopa, neuroleptics drug and postnatal administration
    A. Fredriksson
    T. Archer
    Amino Acids, 2002, 23 : 111 - 132
  • [4] Functional alteration by NMDA antagonist: Effects of L-Dopa, neuroleptics drug and postnatal administration
    Fredriksson, A
    Archer, T
    AMINO ACIDS, 2002, 23 (1-3) : 111 - 132
  • [5] AV-101, a Pro-Drug Antagonist at the NMDA Receptor Glycine Site, Reduces L-Dopa Induced Dyskinesias in MPTP Monkeys
    Bourque, Melanie
    Gregoire, Laurent
    Patel, Waseema
    Dickens, David
    Snodgrass, Ralph
    Di Paolo, Therese
    CELLS, 2022, 11 (22)
  • [6] L-DOPA DIRECTLY AFTER ADMINISTRATION AND WHEN LOSING EFFICACY - RESULTING DYSKINESIAS
    PIERROTDESEILLIGNY, C
    NOUVELLE PRESSE MEDICALE, 1977, 6 (37): : 3368 - 3368
  • [7] ATTEMPTED USE OF HALOPERIDOL IN TREATMENT OF L-DOPA INDUCED DYSKINESIAS
    KLAWANS, HL
    WEINER, WJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1974, 37 (04): : 427 - 430
  • [8] NMDA ANTAGONIST EFFECTS ON THE DEVELOPMENT OF L-DOPA BEHAVIORAL SENSITIZATION IN RATS
    PINHEIROCARRERA, M
    TOMAZ, C
    HUSTON, JP
    CAREY, RJ
    BEHAVIORAL NEUROSCIENCE, 1995, 109 (01) : 34 - 42
  • [9] L-dopa "drug holiday" with amantadine infusions as a treatment of dyskinesias in Parkinson's disease
    Friedman, A.
    Koziorowski, D.
    MOVEMENT DISORDERS, 2006, 21 : S571 - S571
  • [10] SYNERGISM OF THE AMPA-ANTAGONIST NBQX AND THE NMDA-ANTAGONIST CPP WITH L-DOPA IN MODELS OF PARKINSONS-DISEASE
    LOSCHMANN, PA
    LANGE, KW
    KUNOW, M
    RETTIG, KJ
    JAHNIG, P
    HONORE, T
    TURSKI, L
    WACHTEL, H
    JENNER, P
    MARSDEN, CD
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1991, 3 (03) : 203 - 213
12345